Skip To Main Content
Miraz Rahman on Muck Rack

Miraz Rahman

As seen in: King's College London
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Miraz

Contact Miraz, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

King's biotech spinout Pheon Therapeutics Raises $120m to develop novel anticancer agents

|
By David Thurston, Miraz Rahman
| King's College London
The investment raised at the close of its Series B funding round will enable Pheon Therapeutics (Pheon) to take three new Antibody-Drug Conjugates (ADCs), used to treat cancer, through clinical trials. Pheon Therapeutics, a biotech spinout with its origins in research carried out at the Institute of Pharmaceutical Sciences (IPS) at King’s, has raised $120 million in Series B funding to further develop its pre-clinical and clinical pipeline.
Open in Who Shared Issue with article?

King's biotech spinout re-launches with new name and $68 million funding

|
By David Thurston, Miraz Rahman
| King's College London
Pheon Therapeutics, which has its origins in research carried out in the Institute of Pharmaceutical Sciences (IPS), launched on Wednesday 28 September based on a $68 million Series A financing round. The spin-out is focused on the development of novel Antibody-Drug Conjugates (ADCs) for use in oncology, and now has a presence in both London (UK) and Boston (US).
Open in Who Shared Issue with article?

IPS colleagues win major awards at international PharmSci conference

|
By Stuart Jones, Bahijja Raimi-Abraham, Miraz Rahman
| King's College London
The awards included the Academy of Pharmaceutical Sciences' (APS) Science and Emerging Scientist awards alongside multiple invited podiums and poster presentations, at this year’s PharmSci conference.
Open in Who Shared Issue with article?
See all 7 articles